Agilent Technologies Inc. announced the successful completion of its previously announced acquisition of Proscia®, a leading provider of digital-pathology software for clinical and life-sciences customers. Under the terms of the transaction, Agilent acquired Proscia for $240 million in cash at closing, with up to an a…
Abbott, the global healthcare leader, and Novo, a global leader in treatments for serious chronic diseases, announced an expanded strategic collaboration to increase access to originator semaglutide for people living with type 2 diabetes across Asia Pacific. Under the agreement, Abbott will commercialise Plosbrio® (se…
Zuellig Pharma, a leading healthcare solutions company in Asia, announced the strategic acquisition of a specialized clinical supply facility in Hangzhou, China, strengthening its clinical sourcing capabilities to better support domestic and international clinical trials. The Hangzhou facility holds a Drug Distributi…
Brise Pharmaceuticals Co., Ltd. provided an update on its exclusive license agreement with AbbVie, which the companies entered in 2024. Under the terms of the collaboration agreement, Brise is responsible for discovery efforts and AbbVie will lead global development and commercialization activities for two of Brise's …
Fresenius SE & Co. KGaA announced that it has entered an exclusive development agreement with WuXi Biologics, a leading global contract organization for research, development and manufacturing. WuXi Biologics brings proven large-scale biologics development and manufacturing capability, a track record across monocl…
The College of Healthcare Information Management Executives (CHIME) announced a strategic joint venture with ScaleHealth, Inc. to create ScaleHealth, powered by CHIME, LLC, a new innovation ecosystem designed to connect healthcare's most pressing challenges with the innovators, leaders, organizations, and partners cap…
Made Scientific, Inc., a leading U.S.-based clinical- and commercial-stage cell therapy contract development and manufacturing organization (CDMO), and CARR Biosystems, an innovator in cell processing and centrifugal separation technologies for bioprocessing, announced a partnership under which Made Scientific will de…
AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, announced it has entered into a Research Collaboration and License Agreement with Astellas Innovation Management LLC, an affiliate of Astellas Pharma Inc., to discover and develop novel min…
Oracle announced an agreement with AstraZeneca to explore how AI and real-world data can help clinicians identify eligible patients for clinical trials, accelerate evidence generation, and bring relevant research insights into everyday care. The collaboration is expected to combine AstraZeneca's scientific and therape…
Malaysia Healthcare Travel Council (MHTC) and Malayan Banking Berhad (Maybank) formalised a multi-year strategic collaboration to bring the Malaysia Healthcare ecosystem closer to Maybank customers across ASEAN. The collaboration brings together MHTC's medical tourism ecosystem and Maybank's regional network and cus…
Page 1 of 43